ClinVar Miner

Submissions for variant NM_001352514.2(HLCS):c.1156C>T (p.Gln386Ter)

dbSNP: rs2146525207
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001388680 SCV001589754 pathogenic Holocarboxylase synthetase deficiency 2020-05-08 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gln239*) in the HLCS gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in HLCS are known to be pathogenic (PMID: 16134170). This variant has not been reported in the literature in individuals with HLCS-related conditions. This variant is not present in population databases (ExAC no frequency).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.